This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of other and unspecified sites
CD2_BENIGN_OTHER_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna locis aliis et non specificatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified sites
- Benign neoplasms
- Benign neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1191 | 695 | 496 |
| Unadjusted period prevalence (%) | 0.23 | 0.24 | 0.22 |
| Median age at first event (years) | 49.14 | 47.16 | 51.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1071
- Matched controls
- 10710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
323.0
345
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
+∞
323.0
338
*
22899
ICD-8 Finland
Benign neoplasm of other and unspecified organs and tissues
+∞
108.2
102
*
22550
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Peripheral nerves
+∞
102.8
97
*
D36.0
ICD-10 Finland
Benign neoplasm: Lymph nodes
+∞
88.8
84
*
130
Kela drug reimbursment
Malignant tumour
+∞
75.9
72
*
D36.9
ICD-10 Finland
Benign neoplasm: Benign neoplasm of unspecified site
+∞
60.0
57
*
H02AB02
ATC
dexamethasone; systemic
23.6
56.2
81
37
2258X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Other specified sites of nervous system
+∞
55.7
53
*
115
Kela drug reimbursment
Breast cancer
+∞
54.6
52
*
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
51.9
49.4
59
12
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
477.7
46.7
46
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
128.2
46.2
49
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.0
45.9
119
188
PJA12
NOMESCO Finland
Sentinel node biopsy
160.0
44.1
46
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
43.0
41
*
A04AA02
ATC
granisetron; systemic, transdermal
81.9
42.2
47
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
103.8
37.0
40
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.2
34.9
44
12
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
34.6
33
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.2
32.9
191
672
WF002
NOMESCO Finland
Radical radiotherapy
93.1
32.9
36
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
32.5
31
*
116
Kela drug reimbursment
Prostate cancer
+∞
29.3
28
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
27.3
27.2
37
14
JN4BD
NOMESCO Finland
Extensive body CT
4.8
26.5
92
206
DHB00
NOMESCO Finland
Excision of lesion of external nose
53.1
26.3
31
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.6
26.1
62
86
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
138.4
25.7
27
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
133.1
24.7
26
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
24.0
23
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
24.0
23
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
9.3
24.0
50
56
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
23.9
288
1518
L03AA13
ATC
pegfilgrastim; parenteral
245.2
23.7
24
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
127.9
23.7
25
*
HAC20
NOMESCO Finland
Total mastectomy
127.9
23.7
25
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
23.0
22
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
23.0
22
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
23.0
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
234.8
22.7
23
*
JN4AD
NOMESCO Finland
Body CT examination
5.6
22.1
66
125
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
224.4
21.7
22
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.3
21.4
81
198
XX3DW
NOMESCO Finland
Time consuming IT work
4.0
21.1
86
226
L01BC06
ATC
capecitabine; oral
+∞
20.9
20
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
214.0
20.6
21
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
20.4
297
1683
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
20.1
100
311
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
19.8
19
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
107.0
19.6
21
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.3
19.5
38
38
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
35.0
18.9
24
7
Y77
ICPC
Malignant neoplasm prostate
+∞
18.8
18
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
18.8
18
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
18.8
18
*
L02BA01
ATC
tamoxifen; oral
53.5
18.0
21
*
N03AX16
ATC
pregabalin; oral
2.0
17.9
274
1570
L02BG04
ATC
letrozole; oral
10.6
17.7
34
33
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.9
17.5
49
86
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
17.0
44
70
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
16.9
210
1102
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.0
16.9
69
182
A04AA01
ATC
ondansetron; systemic, rectal
5.5
16.6
49
92
WX110
NOMESCO Finland
Local anesthesy
1.7
16.6
688
5437
DHA10
NOMESCO Finland
Biopsy of cavity of nose
11.8
16.6
30
26
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
172.6
16.5
17
*
C50.99
ICD-10 Finland
Breast, unspecified
172.6
16.5
17
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
40.8
16.4
20
5
ZXA05
NOMESCO Finland
Left side
1.9
16.4
277
1642
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.0
16.2
52
108
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
11.0
16.0
30
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
16.0
424
2916
S18
ICPC
Laceration/cut
1.8
15.9
415
2837
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.7
15
*
2401
FHL
Nerve exploration (includes biopsy and removal of local change)
29.1
15.2
20
7
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
5.2
15.0
46
91
N02AA05
ATC
oxycodone; systemic
2.4
14.9
128
563
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
32.2
14.8
19
6
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.7
887
7703
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
14.6
14
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
14.6
14
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
14.6
14
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
14.6
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
152.0
14.5
15
*
HA1AA
NOMESCO Finland
X-ray mammography
4.4
14.3
51
119
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
7.5
14.3
33
45
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
20.3
13.8
20
10
SPAT1153
SPAT
Removal of sutures
1.8
13.7
314
2040
ZXA00
NOMESCO Finland
Right side
1.8
13.7
283
1780
L03AA02
ATC
filgrastim; parenteral
76.1
13.6
15
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
13.6
13
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
13.6
13
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.4
13.4
65
199
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
21.5
13.4
19
9
Z31.5
ICD-10 Finland
Genetic counselling
3.8
13.2
55
149
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
12.5
12
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
13.4
12.5
21
16
N03AX12
ATC
gabapentin; oral
2.0
12.2
176
973
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
27.0
12.1
16
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
12.0
349
2414
B01AB05
ATC
enoxaparin; parenteral
1.7
11.9
274
1771
ACB99
NOMESCO Finland
Other operation for lesion of peripheral nerve: other or unspecified
47.2
11.9
14
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
11.9
94
394
L02AE02
ATC
leuprorelin; implant, parenteral
9.1
11.8
24
27
N02AX02
ATC
tramadol; systemic, rectal
1.6
11.6
416
3039
HAB40
NOMESCO Finland
Wedge excision of mammary gland
11.2
11.6
21
19
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.7
11.6
24
28
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
8.7
11.6
24
28
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
11.5
11
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
3.8
11.5
48
131
UJF32
NOMESCO Finland
Coloscopy
1.8
11.5
248
1573
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
121.3
11.4
12
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.1
11.4
27
39
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
11.4
192
1122
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
12.0
11.4
20
17
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
10.7
11.3
21
20
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
35.4
11.3
14
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.6
11.2
50
144
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
4.2
11.0
41
101
Z51.5
ICD-10 Finland
Palliative care
4.9
10.7
34
71
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.3
10.7
53
166
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
10.7
72
278
A02BC02
ATC
pantoprazole; systemic
1.5
10.5
639
5247
JN4CD
NOMESCO Finland
Very extensive body CT
5.7
10.5
29
52
WF004
NOMESCO Finland
Palliative radiotherapy
111.1
10.4
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
111.1
10.4
11
*
L02BB03
ATC
bicalutamide; oral
+∞
10.4
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
10.4
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.4
10
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
32.9
10.3
13
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.3
10.3
37
88
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
4.4
10.3
36
84
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
4.6
10.2
34
75
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
10.1
86
374
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.4
10.1
18
16
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.5
10.1
21
25
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.5
10.0
81
346
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
40.5
10.0
12
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
40.5
10.0
12
*
WX402
NOMESCO Finland
General anaesthesia
2.0
9.9
141
772
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
5.6
9.7
27
49
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
11.5
9.6
17
15
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.2
9.5
19
21
P01AB01
ATC
metronidazole; oral, rectal
1.5
9.5
386
2869
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
9.5
102
500
ZX070
NOMESCO Finland
Intensity modified radiotherapy
100.9
9.4
10
*
X76
ICPC
Malignant neoplasm breast female
100.9
9.4
10
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
9.4
9
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
6.1
9.2
24
40
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.4
9.1
75
325
WZC30
NOMESCO Finland
Teaching
2.1
9.0
103
514
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
9.0
83
379
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
37.0
9.0
11
*
A02BC05
ATC
esomeprazole; systemic
1.5
8.9
395
2983
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
6.9
8.9
21
31
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
4.3
8.8
31
73
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
50.4
8.7
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
50.4
8.7
10
*
A02BC03
ATC
lansoprazole; oral
1.6
8.6
294
2086
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.8
8.6
27
57
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
16.4
8.6
13
8
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
8.6
385
2911
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
8.5
282
1988
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
90.7
8.4
9
*
R03AC02
ATC
salbutamol; inhalant
1.5
8.4
515
4150
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
8.3
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.3
8
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
8.3
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
8.3
8
*
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
8.3
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.3
8
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
8.3
163
995
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
33.6
8.1
10
*
ZZR00
NOMESCO Finland
Flap of skin
11.8
8.1
14
12
J01DB01
ATC
cefalexin; oral
1.5
8.0
810
7192
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
8.0
106
566
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.9
267
1883
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
13.1
7.9
13
10
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
7.9
107
576
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
10.9
7.8
14
13
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.7
151
919
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.0
7.7
29
74
J01FF01
ATC
clindamycin; systemic
1.6
7.7
247
1723
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
25.2
7.6
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
80.6
7.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
80.6
7.4
8
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
80.6
7.4
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
80.6
7.4
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
13.5
7.4
12
9
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
7.3
34
104
2312
FHL
Extirpation or destruction
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
7.3
7
*
ACB18
NOMESCO Finland
Excision of local lesion of brachial plexus
+∞
7.3
7
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.9
7.3
28
73
R13
ICD-10 Finland
Dysphagia
2.2
7.3
68
314
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.2
82
412
M79.6
ICD-10 Finland
Pain in limb
1.5
7.2
344
2615
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
7.2
72
342
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.1
181
1187
R4110
NOMESCO Finland
Physiotherapy
1.5
7.1
231
1614
A06AD11
ATC
lactulose; oral
1.8
7.1
129
770
R51.80
ICD-10 Finland
Headache
1.7
7.0
142
873
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.0
118
688
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
13.9
6.9
11
8
XKD00
NOMESCO Finland
Uroflowmetry
1.8
6.9
121
715
R51
ICD-10 Finland
Headache
2.4
6.8
54
228
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
6.8
194
1311
WW500
NOMESCO Finland
Blood transfusion
3.7
6.8
28
78
ACB15
NOMESCO Finland
Excision of local lesion of tibial nerve
40.3
6.8
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
40.3
6.8
8
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
16.8
6.7
10
6
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
6.7
64
297
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.6
6.7
28
79
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
6.7
36
123
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
6.5
6.6
16
25
JAH00
NOMESCO Finland
Laparotomy
3.9
6.6
25
65
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.6
252
1820
JN3AD
NOMESCO Finland
Abdominal CT examination
2.2
6.5
66
317
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
6.4
28
82
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.5
6.4
49
205
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
70.3
6.4
7
*
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
70.3
6.4
7
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
70.3
6.4
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
6.4
133
824
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.5
6.4
46
188
D33.30
ICD-10 Finland
Acoustic neuroma
6.6
6.3
15
23
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.2
6.3
18
35
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.3
366
2873
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.8
6.3
38
140
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.3
6
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
6.3
6
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
6.3
6
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
+∞
6.3
6
*
L02BG06
ATC
exemestane; oral
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
6.2
96
542
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
26.8
6.2
8
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
26.8
6.2
8
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
26.8
6.2
8
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
6.2
259
1908
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.5
6.2
20
45
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.4
6.1
48
206
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.6
6.1
10
8
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
6.0
79
422
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.7
6.0
24
66
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
137
445
3.35
34.20
3.7
1.5
61.2
3.4
ug/l
0.50
113
335
576
3985
1.86
23.98
4.7
3.6
—
—
—
0
0
620
4402
1.85
23.64
6.7
3.8
10.7
11.7
umol/l
1.48
589
4135
681
5029
1.83
22.35
9.4
6.5
4.0
4.2
e9/l
2.06
608
4368
62
165
3.91
20.75
3.1
2.0
76.1
84.7
u/ml
0.06
49
131
51
125
4.22
19.07
1.3
1.2
—
—
—
0
0
597
4419
1.70
17.80
6.9
5.7
1.2
1.2
mmol/l
0.16
520
3762
544
3982
1.67
16.49
7.0
5.2
1.2
1.2
mmol/l
0.42
502
3546
514
3732
1.66
15.91
5.0
3.8
35.3
35.8
g/l
1.57
468
3434
416
2894
1.67
14.96
3.5
2.1
2.4
2.4
mmol/l
0.40
361
2439
847
7048
1.70
14.90
8.9
5.4
75.7
75.7
u/l
0.00
801
6534
136
695
2.08
13.11
2.0
2.0
0.2
0.2
g/l
1.40
127
632
678
5437
1.57
12.89
5.6
4.3
6.6
6.7
mmol/l
0.74
646
5060
299
1999
1.66
12.09
2.4
2.0
—
—
—
0
0
840
7162
1.59
11.54
4.6
4.1
11.2
11.5
mm/h
0.32
773
6620
393
2871
1.55
10.77
2.9
2.3
62.6
56.9
u/l
0.49
366
2644
169
1003
1.80
10.38
7.4
7.6
5.2
5.1
kpa
0.44
162
960
169
1003
1.80
10.38
7.3
7.5
12.6
11.7
kpa
1.14
164
959
168
1001
1.79
10.17
7.4
7.6
1.4
1.2
mmol/l
0.30
127
779
203
1288
1.69
9.83
3.5
2.7
0.8
0.8
mmol/l
1.31
192
1186
144
838
1.82
9.41
2.8
1.7
359.5
365.2
nmol/l
0.13
132
759
1047
9592
1.76
9.17
17.9
12.0
22.6
22.5
mg/l
0.03
851
7403
109
602
1.89
8.40
1.7
1.5
—
—
—
0
0
18
39
4.67
7.89
5.1
1.1
42.1
55.0
u/ml
—
6
11
325
2409
1.48
7.87
3.1
2.8
0.7
0.4
e6/l
0.57
264
1817
384
2943
1.45
7.82
3.8
2.7
31.6
32.7
u/l
0.18
358
2803
150
936
1.69
7.66
2.7
2.2
10.5
8.0
umol/l
0.44
127
810
705
6067
1.40
7.19
5.2
4.3
648.4
2934.0
e6/l
1.33
11
80
453
3642
1.39
6.84
4.0
3.6
26.5
50.4
ng/l
1.51
300
2473
95
537
1.84
6.83
3.4
3.0
4.3
4.6
pmol/l
2.10
83
460
1067
9974
1.67
6.80
20.3
14.3
139.8
139.7
mmol/l
0.34
1040
9705
130
806
1.69
6.79
4.6
3.1
238.5
234.8
u/l
0.16
121
757
46
200
2.35
6.65
1.5
1.3
12.5
10.2
u/l
0.41
38
165
1068
9999
1.66
6.59
20.2
14.4
4.0
4.0
mmol/l
1.34
1035
9716
171
1144
1.58
6.59
4.3
5.0
1.0
1.0
mmol/l
0.01
160
1042
11
9
12.32
6.58
1.4
1.1
—
—
—
0
0
119
733
1.69
6.37
2.1
2.2
66.7
68.6
ml/min/173m2
0.19
46
299
838
7505
1.39
6.23
4.7
3.9
14.9
14.8
pmol/l
0.53
771
6868
381
3020
1.38
6.12
2.3
2.2
241.6
249.8
u/l
0.04
358
2843
250
1845
1.45
6.01
2.6
2.3
6.0
6.5
e6/l
0.24
221
1604
18
49
3.71
5.93
2.8
1.9
1102.4
1032.1
e6/l
—
5
20
477
3943
1.35
5.80
2.3
2.3
78.4
77.7
nmol/l
0.20
421
3503
971
8987
1.44
5.46
5.4
4.7
1.9
2.0
mu/l
0.67
888
8264
199
1433
1.47
5.40
2.0
1.7
—
—
—
0
0
272
2075
1.40
5.39
1.8
1.7
1.1
1.1
mg/l
0.04
211
1580
204
1477
1.46
5.39
2.7
2.4
0.9
1.5
e6/l
1.48
134
841
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
20
63
3.21
5.33
1.5
1.2
—
—
—
0
0
315
2471
1.37
5.27
5.1
3.8
0.0
0.0
estimate
0.88
100
780
14
35
4.04
5.17
2.1
1.9
—
—
—
0
0
122
800
1.58
5.12
2.9
2.0
37.3
41.2
u/l
0.20
97
671
15
40
3.79
5.10
1.7
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
230
2.04
4.80
2.5
2.9
0.4
0.4
u/ml
0.37
26
135
76
449
1.74
4.77
7.9
9.2
24.2
24.4
mmol/l
0.14
69
414
15
42
3.60
4.77
2.1
1.8
19.6
12.5
%
—
9
21
868
7951
1.34
4.69
20.7
14.4
13.7
13.6
%
0.82
853
7757
188
1382
1.43
4.55
2.2
2.4
13.2
13.6
umol/l
0.25
168
1267
215
1620
1.40
4.53
3.1
2.1
2.5
2.4
mmol/l
2.38
184
1410
44
222
2.02
4.50
2.0
2.1
6053.7
3311.2
u/l
—
9
94
92
582
1.63
4.49
2.6
2.1
11.8
14.5
nmol/l
2.43
84
515
539
4654
1.29
4.43
5.8
4.8
0.0
0.0
estimate
0.50
102
801
537
4638
1.29
4.39
4.5
3.5
0.0
0.0
estimate
0.00
100
798
706
6322
1.29
4.31
3.3
3.0
48.7
46.4
u/l
0.21
651
5897
292
2328
1.34
4.29
2.5
2.2
3.0
2.9
mg/l
0.51
242
1967
94
605
1.60
4.29
1.3
1.2
140.2
224.5
u/ml
0.67
87
560
46
243
1.93
4.16
1.5
1.4
249.8
307.3
ug/g
1.32
33
147
157
1138
1.44
4.10
2.2
2.5
23.6
24.0
%
0.10
125
966
106
710
1.54
4.09
2.7
3.7
84.6
87.9
ng/l
0.13
89
621
539
4695
1.27
4.00
4.5
3.5
0.0
0.0
estimate
0.25
104
779
426
3605
1.28
4.00
4.9
3.7
—
—
—
0
0
153
1112
1.43
3.94
2.2
2.3
170.2
138.5
ug/g
0.33
128
881
266
2127
1.32
3.79
1.3
1.3
1.1
1.7
u/ml
1.12
68
581
474
4086
1.27
3.77
2.9
2.7
124.2
117.0
ug/l
0.24
432
3768
164
1223
1.40
3.66
24.3
24.9
1.2
1.4
inr
0.57
24
177
34
170
2.03
3.62
1.5
1.5
—
—
—
0
0
1078
10338
1.45
3.50
12.3
8.8
25.5
26.2
u/l
0.87
1048
9945
220
1737
1.33
3.41
1.3
1.3
36.0
37.1
iu/ml
0.04
66
558
137
1004
1.41
3.39
2.0
1.7
—
—
—
0
0
7
10
7.03
3.36
2.0
1.8
—
—
—
0
0
57
347
1.67
3.29
1.5
1.3
28.7
27.6
iu/l
0.08
45
306
32
163
1.99
3.26
1.6
1.5
—
—
—
0
0
164
1249
1.36
3.22
2.2
2.4
2.3
2.3
g/l
0.08
149
1162
49
288
1.73
3.22
1.7
1.7
257.5
299.8
mu/l
0.84
43
258
98
682
1.48
3.20
2.7
1.6
65.4
67.3
g/l
1.65
89
612
136
1007
1.40
3.17
2.1
1.7
—
—
—
0
0
13
44
2.98
3.14
1.5
1.5
—
—
—
0
0
295
2448
1.27
3.13
2.4
2.3
2143.0
5061.2
umol/l
1.16
264
2116
15
56
2.70
3.06
1.5
2.4
—
—
—
0
0
40
225
1.80
3.06
1.8
1.6
—
—
—
0
0
175
1359
1.34
3.03
2.8
2.6
3.0
3.2
e6/l
0.09
104
722
11
35
3.16
2.93
2.3
1.1
—
—
—
0
0
11
35
3.16
2.93
2.3
1.1
—
—
—
0
0
18
76
2.39
2.90
1.3
1.4
—
—
—
0
0
9
22
4.11
2.88
1.0
1.2
—
—
—
0
0
9
22
4.11
2.88
1.0
1.2
—
—
—
0
0
9
22
4.11
2.88
1.0
1.2
—
—
—
0
0
77
522
1.51
2.87
1.7
1.5
—
—
—
0
0
1114
10805
1.48
2.83
26.3
17.7
254.0
251.3
e9/l
0.69
1095
10521
16
65
2.48
2.79
1.4
1.4
—
—
—
0
0
1114
10812
1.47
2.74
26.4
17.7
4.5
4.5
e12/l
1.66
1091
10497
39
226
1.75
2.73
1.3
1.3
1290.2
956.3
e6/l
0.15
33
189
39
226
1.75
2.73
1.2
1.3
6.1
43.1
e6/l
0.82
30
183
1114
10814
1.47
2.72
26.4
17.8
6.6
6.7
e9/l
1.79
1091
10496
1114
10815
1.46
2.70
26.6
17.8
134.6
136.3
g/l
3.57
1099
10651
224
1829
1.28
2.69
1.9
1.8
1105.0
1174.0
nmol/l
0.47
162
1388
228
1868
1.27
2.66
4.3
3.8
163.3
448.3
ng/l
2.62
181
1457
10
32
3.14
2.65
1.1
1.2
—
—
—
0
0
10
32
3.14
2.65
1.1
1.2
—
—
—
0
0
10
32
3.14
2.65
1.1
1.2
—
—
—
0
0
10
32
3.14
2.65
1.1
1.2
—
—
—
0
0
117
874
1.38
2.62
4.1
2.9
—
—
—
0
0
26
134
1.96
2.61
1.5
1.5
—
—
—
0
0
94
678
1.42
2.58
2.9
2.4
31.5
19.6
au/ml
—
10
33
8
20
4.02
2.57
8.9
1.9
—
—
—
0
0
207
1687
1.27
2.52
1.4
1.3
10.2
11.8
u/ml
0.13
86
678
23
115
2.02
2.52
1.6
1.5
—
—
—
0
0
20
96
2.10
2.43
1.5
1.4
—
—
—
0
0
92
670
1.40
2.41
3.8
2.6
1.2
1.2
mmol/l
0.05
77
553
5
8
6.27
2.37
1.2
1.0
—
—
—
0
0
50
324
1.57
2.33
7.6
3.9
1.1
1.4
mmol/l
2.55
50
317
51
333
1.56
2.30
1.6
2.0
—
—
—
0
0
31
178
1.76
2.28
1.4
1.3
—
—
—
0
0
31
178
1.76
2.28
1.4
1.3
—
—
—
0
0
39
240
1.65
2.25
1.5
1.2
—
—
—
0
0
44
280
1.59
2.22
1.2
1.1
—
—
—
0
0
951
9088
1.23
2.18
16.2
10.7
81.6
80.4
ml/min/173m2
1.02
835
7354
53
354
1.52
2.18
1.5
1.7
—
—
—
0
0
22
115
1.93
2.16
1.5
1.4
—
—
—
0
0
57
389
1.49
2.12
1.4
1.2
0.2
0.5
u/ml
—
10
35
75
540
1.42
2.12
4.8
3.6
1.7
1.8
mmol/l
0.09
53
402
107
817
1.34
2.12
3.6
3.1
2.1
2.0
mmol/l
0.06
93
653
43
276
1.58
2.11
1.2
1.1
—
—
—
0
0
8
25
3.21
2.09
1.8
1.3
—
—
—
0
0
39
246
1.61
2.06
2.9
1.4
50.4
57.4
mg/l
0.10
33
200
39
246
1.61
2.06
2.9
1.4
111.8
44.4
mg/l
0.81
33
201
317
2764
1.20
2.04
3.1
3.0
891.8
1398.3
ng/l
2.40
263
2344
40
255
1.59
2.03
1.2
1.3
609.8
478.7
mg/l
0.48
40
240
29
170
1.72
2.01
3.7
2.2
18.1
16.4
%
1.47
17
81
117
913
1.31
2.01
2.0
1.9
—
—
—
0
0
41
264
1.57
2.00
3.1
3.1
—
—
—
0
0
112
873
1.31
1.94
2.2
2.5
5.8
7.6
ug/l
0.63
101
772
151
1226
1.27
1.92
9.2
6.5
—
—
—
0
0
187
1560
1.24
1.87
1.5
1.5
—
—
—
0
0
305
2671
1.19
1.86
1.7
1.7
1.4
1.4
mmol/l
0.16
261
2266
17
86
1.99
1.85
4.2
3.0
1.3
1.5
%
0.09
12
63
35
222
1.59
1.83
1.5
2.4
3.3
3.6
g/l
0.96
35
214
77
573
1.37
1.83
4.8
3.6
5.3
5.2
kpa
0.38
69
532
23
130
1.78
1.82
1.3
1.3
0.5
0.7
nmol/l
1.55
23
121
105
820
1.31
1.81
1.9
1.8
—
—
—
0
0
106
829
1.31
1.81
3.2
3.1
122.2
202.3
ng/l
3.32
96
760
7
23
3.06
1.80
4.3
4.0
—
—
—
0
0
12
54
2.23
1.74
1.2
1.3
—
—
—
0
0
442
4012
1.16
1.72
2.1
2.0
97.1
95.7
pmol/l
0.26
217
2042
8
30
2.68
1.72
2.0
1.5
—
—
—
0
0
5
13
3.86
1.71
1.0
1.1
89.0
115.1
%
—
5
13
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
5
13
3.86
1.71
1.6
1.0
—
—
—
0
0
5
13
3.86
1.71
1.6
1.0
—
—
—
0
0
247
2144
1.19
1.66
5.1
3.9
1.0
1.0
kg/l
0.11
30
300
35
231
1.53
1.58
1.2
1.2
4.2
3.8
mmol/l
0.98
35
218
6
20
3.01
1.58
1.3
1.3
—
—
—
0
0
170
1433
1.22
1.56
1.5
1.4
—
—
—
0
0
27
169
1.61
1.53
2.4
1.6
—
—
—
0
0
45
318
1.43
1.48
2.7
1.4
10.2
10.6
g/l
0.30
37
270
39
268
1.47
1.48
1.6
1.3
203.3
230.9
miu/ml
0.23
24
123
19
109
1.76
1.47
1.1
1.3
—
—
—
0
0
10
45
2.23
1.46
1.4
1.2
—
56.7
%
—
0
6
7
28
2.51
1.45
1.0
1.5
—
—
—
0
0
261
2303
1.17
1.45
1.6
1.5
20.2
21.2
nmol/l
0.46
220
1957
17
96
1.78
1.39
1.7
1.6
—
—
—
0
0
15
82
1.84
1.36
1.1
1.1
0.0
1.9
u/ml
—
9
40
35
242
1.46
1.31
1.2
1.1
—
—
—
0
0
21
129
1.64
1.30
1.1
1.2
2.9
7.3
u/ml
—
9
55
312
2815
1.15
1.28
5.0
3.6
2.0
1.9
ug/l
0.37
275
2539
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
45
2.01
1.23
1.0
1.2
—
—
—
0
0
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
28
188
1.50
1.22
3.1
2.1
138.2
132.9
g/l
0.50
22
137
16
93
1.73
1.21
1.8
1.4
0.2
0.3
nmol/l
—
8
78
42
306
1.39
1.21
1.6
1.5
—
—
—
0
0
27
181
1.50
1.19
1.9
1.5
—
—
—
0
0
912
8824
1.14
1.18
18.4
13.2
40.1
40.1
%
0.02
629
6316
11
199
0.55
1.18
3.2
3.7
17.6
24.4
mg/l
—
5
130
40
291
1.39
1.16
2.8
1.4
0.5
0.4
g/l
0.11
35
252
17
102
1.68
1.16
1.6
1.5
—
—
—
0
0
7
30
2.34
1.12
1.3
1.1
—
—
—
0
0
35
251
1.41
1.11
1.3
1.3
—
—
—
0
0
27
184
1.48
1.11
1.6
3.0
28.7
35.0
umol/l
1.04
22
164
985
9593
1.15
1.11
4.9
4.6
6.0
6.0
mmol/l
0.01
895
8764
54
416
1.31
1.11
5.4
3.3
48.9
48.7
%
0.02
54
409
25
168
1.50
1.10
3.5
3.7
57.0
57.5
%
0.06
25
168
44
329
1.35
1.10
1.3
1.6
—
—
—
0
0
5
21
2.39
1.09
1.2
1.9
—
—
—
0
0
30
211
1.43
1.07
1.4
1.1
—
—
—
0
0
45
341
1.33
1.04
2.7
1.4
—
—
—
0
0
45
341
1.33
1.04
2.7
1.4
7.2
7.5
g/l
0.57
34
261
45
341
1.33
1.04
2.7
1.4
3.5
3.9
g/l
1.23
33
251
23
154
1.50
1.04
1.1
1.1
1.1
2.1
u/ml
—
9
61
37
272
1.37
1.04
1.7
1.7
—
—
—
0
0
9
46
1.96
1.03
1.1
1.2
126.6
517.3
u/l
—
9
41
234
2102
1.14
1.03
1.7
1.7
29189689.8
31834341.4
pmol/l
0.03
185
1734
632
6014
1.11
1.01
3.1
2.9
—
—
—
0
0
9
48
1.88
1.00
1.9
2.7
2815.4
1036.1
u/ml
—
9
48
939
9139
1.13
0.97
6.1
5.8
39.2
39.9
mmol/mol
1.76
867
8515
66
534
1.25
0.95
1.6
1.6
—
—
—
0
0
7
37
1.90
0.94
1.1
1.1
—
—
—
0
0
42
323
1.31
0.90
2.8
1.4
3.0
3.1
g/l
0.05
34
254
6
29
2.07
0.89
2.3
1.2
—
—
—
0
0
6
29
2.07
0.89
2.3
1.2
—
—
—
0
0
45
351
1.29
0.88
1.6
1.8
1.5
1.5
g/l
0.19
36
307
8
43
1.87
0.87
1.3
1.5
—
—
—
0
0
6
30
2.00
0.87
1.2
1.1
—
—
—
0
0
38
291
1.32
0.85
1.9
1.5
0.2
0.2
g/l
0.87
38
277
12
72
1.67
0.85
1.2
1.1
—
—
—
0
0
20
137
1.47
0.84
1.2
1.1
—
—
—
0
0
60
490
1.24
0.82
1.4
1.3
—
—
—
0
0
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
8
47
1.71
0.80
1.0
1.1
—
—
—
0
0
20
139
1.45
0.79
1.1
1.1
—
—
—
0
0
23
165
1.40
0.78
3.1
3.4
3.9
4.0
e9/l
0.09
23
165
10
59
1.70
0.76
1.2
1.2
—
—
—
0
0
15
99
1.52
0.75
1.0
1.1
—
—
—
0
0
20
141
1.43
0.75
1.4
1.5
—
—
—
0
0
50
406
1.24
0.74
3.1
3.2
24.2
24.2
mmol/l
0.01
45
361
8
136
0.59
0.73
1.0
1.0
—
—
—
0
0
14
92
1.53
0.72
2.7
3.5
—
—
—
0
0
10
60
1.67
0.72
1.2
1.2
—
—
—
0
0
11
68
1.62
0.72
1.5
1.5
169932.0
132637.6
e6/l
—
5
38
9
57
1.58
0.71
1.1
1.2
—
—
—
0
0
12
77
1.56
0.68
1.2
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
157.6
260.1
pmol/l
—
5
17
7
42
1.67
0.68
1.9
2.1
26.2
212.5
ug/l
—
7
36
58
486
1.20
0.66
1.1
1.0
—
—
—
0
0
16
112
1.43
0.63
1.0
1.1
—
—
—
0
0
130
1168
1.13
0.62
1.4
1.8
1.5
1.5
%
0.03
112
1025
37
299
1.25
0.60
1.9
1.5
1.2
1.2
g/l
0.27
37
281
0
23
0.00
0.58
0.0
2.0
—
1.2
—
0
23
18
132
1.37
0.57
1.1
1.1
—
—
—
0
0
6
37
1.62
0.55
1.5
1.3
177.0
197.2
u/l
—
6
37
15
107
1.41
0.55
1.0
1.1
—
—
—
0
0
6
38
1.58
0.54
1.0
1.0
—
—
—
0
0
9
60
1.50
0.54
1.4
1.6
—
—
—
0
0
9
62
1.45
0.53
1.3
1.4
—
56.7
—
0
6
9
62
1.45
0.53
1.3
1.4
—
856.3
—
0
8
10
66
1.52
0.52
1.1
1.1
—
—
—
0
0
12
169
0.71
0.52
1.3
1.5
—
—
—
0
0
6
98
0.61
0.52
1.3
1.5
—
—
—
0
0
24
188
1.28
0.51
1.2
1.2
—
—
—
0
0
1009
9950
1.09
0.50
5.2
5.0
2.8
2.8
mmol/l
0.07
924
9214
43
362
1.19
0.50
2.3
1.8
—
—
—
0
0
20
154
1.30
0.48
1.3
1.5
—
—
—
0
0
33
274
1.21
0.45
1.5
1.3
—
—
—
0
0
23
286
0.80
0.45
1.5
1.5
—
—
—
0
0
240
2265
1.07
0.44
5.0
3.6
20.5
24.2
%
3.65
127
989
9
130
0.69
0.43
1.2
1.6
—
—
—
0
0
5
31
1.62
0.43
1.6
1.5
—
—
—
0
0
5
31
1.62
0.43
1.6
1.5
—
—
—
0
0
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
13
97
1.34
0.39
7.8
1.8
32.5
33.3
pg
0.31
13
97
990
9785
1.07
0.37
4.6
4.5
4.7
4.7
mmol/l
0.18
913
9107
33
385
0.85
0.36
1.3
1.7
2.0
4.5
mg/l
0.99
27
273
23
190
1.21
0.35
3.9
3.5
0.8
0.8
nmol/l
0.27
18
150
19
154
1.24
0.34
1.3
1.3
—
13.4
—
0
5
17
136
1.25
0.33
1.4
1.3
123.0
110.3
u/ml
—
5
29
24
201
1.20
0.32
3.9
2.6
1.3
1.5
mmol/l
1.19
24
193
10
74
1.35
0.32
1.4
1.4
0.9
1.0
g/l
—
10
74
12
154
0.78
0.32
1.4
1.4
—
—
—
0
0
12
154
0.78
0.32
1.4
1.4
—
—
—
0
0
128
1200
1.07
0.31
4.2
4.7
32.7
32.7
%
0.00
85
823
12
153
0.78
0.30
1.4
1.4
—
—
—
0
0
12
153
0.78
0.30
1.4
1.4
—
—
—
0
0
10
75
1.34
0.30
1.6
1.7
—
—
—
0
0
82
889
0.92
0.30
1.6
1.8
—
—
—
0
0
27
313
0.86
0.29
1.4
1.4
—
—
—
0
0
16
130
1.23
0.28
4.0
5.2
1809.8
486.6
iu/ml
—
5
17
22
187
1.18
0.26
4.1
2.7
6.8
7.4
mmol/l
0.80
22
180
5
40
1.25
0.22
1.4
1.7
—
—
—
0
0
5
40
1.25
0.22
1.4
1.7
—
—
—
0
0
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
5
41
1.22
0.22
1.6
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
6.7
—
6.1
—
0
10
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
0.5
—
0
12
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
4.2
—
—
—
0
0
27
240
1.13
0.20
2.2
1.6
16331.1
13041.4
e6/l
0.21
21
181
303
3099
0.97
0.16
4.1
3.9
10.2
9.3
mg/mmol
0.08
197
1942
8
70
1.14
0.16
1.3
1.5
9.4
12.3
umol/l
—
8
65
11
92
1.20
0.16
1.2
1.2
—
—
—
0
0
32
294
1.09
0.14
1.6
1.6
0.1
0.1
iu/ml
—
7
52
61
645
0.94
0.14
1.3
1.2
132.7
130.4
iu/ml
0.02
24
264
16
181
0.88
0.14
1.7
1.4
—
—
—
0
0
31
336
0.92
0.14
2.0
1.7
—
—
—
0
0
9
107
0.84
0.13
1.1
1.2
—
—
—
0
0
48
454
1.06
0.11
2.6
1.9
—
—
—
0
0
12
136
0.88
0.11
1.3
1.0
2.3
2.1
u/ml
—
5
60
976
9718
1.02
0.10
4.6
4.4
1.5
1.5
mmol/l
0.92
897
8988
5
44
1.14
0.10
1.4
1.1
276.9
69.7
u/l
—
5
32
5
44
1.14
0.10
2.4
2.2
48.8
56.7
umol/l
—
5
33
164
1604
1.03
0.09
3.3
2.6
0.7
0.7
ug/l
0.28
112
994
6
55
1.09
0.09
2.0
1.5
—
—
—
0
0
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
15
164
0.91
0.08
2.7
1.6
—
—
—
0
0
8
76
1.05
0.07
2.0
1.7
—
—
—
0
0
8
76
1.05
0.07
1.3
1.2
—
—
—
0
0
8
76
1.05
0.07
1.3
1.2
—
—
—
0
0
8
76
1.05
0.07
4.3
2.4
—
—
—
0
0
8
78
1.03
0.07
1.3
1.2
—
—
—
0
0
8
78
1.03
0.07
1.3
1.2
—
—
—
0
0
8
78
1.03
0.07
1.3
1.2
—
—
—
0
0
23
245
0.94
0.07
2.2
2.4
233.2
102.1
ug/min
0.30
13
155
26
247
1.05
0.05
2.1
1.9
5.0
4.9
iu/l
0.02
12
91
27
259
1.04
0.04
1.2
1.3
—
—
—
0
0
14
131
1.07
0.03
1.4
1.3
—
—
—
0
0
941
9393
1.01
0.03
4.1
4.0
1.3
1.3
mmol/l
0.14
863
8622
11
102
1.08
0.03
1.1
1.5
—
—
—
0
0
14
134
1.05
0.00
1.4
1.5
58.6
63.3
%
—
9
86
17
164
1.04
0.00
1.2
1.2
—
—
—
0
0
312
3113
1.00
0.00
3.2
3.1
7.1
7.5
mmol/l
0.90
266
2654
15
154
0.97
0.00
1.1
1.2
188.4
230.4
u/ml
—
7
91
10
102
0.98
0.00
1.4
1.2
—
—
—
0
0
10
101
0.99
0.00
1.4
1.2
—
—
—
0
0
41
412
0.99
0.00
1.9
2.1
45.2
39.2
u/l
0.56
36
362
11
113
0.97
0.00
1.5
1.7
—
—
—
0
0
10
105
0.95
0.00
1.4
1.2
—
—
—
0
0
10
105
0.95
0.00
1.4
1.2
—
—
—
0
0
10
105
0.95
0.00
1.4
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
8.0
—
0
9
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
10
100
1.00
0.00
1.4
1.2
—
—
—
0
0
5
59
0.85
0.00
1.4
1.2
—
—
—
0
0
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OTHER_NOS_EXALLC – Benign neoplasm of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).